Inclacumab (Anti-P-Selectin / CD62p)
Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2616 |
Sku # | A2616-1mg |
Pricing | 1mg, $570.00 |